Breakthrough in Preventing Steroid-Induced Bone Damage: Targeting Key Proteins for Bone Health
New research uncovers how blocking the protein Basigin can prevent and reverse bone damage caused by long-term steroid use, offering hope for osteoporosis and age-related bone loss treatments.
Recent research from UC Davis Health has unveiled promising advancements in protecting bones from damage caused by long-term steroid use. The study focuses on a protein called Basigin, which becomes activated in stem cells during steroid treatment. This activation contributes to weakening bones and causes abnormalities in blood vessels within bone tissue. By inhibiting Basigin, scientists observed not only protection but also restoration of bone strength in animal models. These findings suggest a novel therapeutic approach for conditions like osteoporosis, especially in patients requiring prolonged steroid therapy.
The research, published in Nature Communications, highlighted that glucocorticoids—common anti-inflammatory medications such as prednisone—are widely prescribed for various ailments, including asthma, arthritis, autoimmune diseases, and COVID-19. Despite their benefits, long-term use has a detrimental impact on bone integrity, increasing fracture risks. The study demonstrated that glucocorticoids disrupt normal skeletal stem cell function and interfere with blood vessel formation in bones, partly due to Basigin release.
By using antibodies to block Basigin and genetically removing it from stem cells, researchers successfully prevented bone loss and even reversed existing damage. Notably, older mice with compromised bone health also showed significant improvements after Basigin inhibition, pointing toward potential treatments for age-related osteoporosis.
This discovery paves the way for targeted therapies that could safeguard bone health during steroid treatment and aging, potentially improving quality of life for millions. Lead researcher Thomas H. Ambrosi emphasized that identifying Basigin as a key driver of bone deterioration opens new avenues for developing drugs that maintain strong, healthy bones even with necessary long-term steroid use.
For more details, refer to the original publication in Nature Communications (2025).
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI Tool Enhances Heart Disease Detection Using Standard ECG Data
A cutting-edge AI tool analyzes routine ECG data to detect hidden structural heart diseases, promising earlier diagnosis and treatment opportunities. Developed by Columbia University researchers, EchoNext offers a cost-effective, non-invasive method to identify patients needing further cardiac evaluation, potentially saving countless lives.
Public Health and Private Equity: The Implications of Walgreens' Buyout for Future Pharmacy Care
Exploring how Walgreens' acquisition by private equity could reshape the future of pharmacy care, impacting access, innovation, and public health in the United States.
Despite Relaxed Regulations, Access to Opioid Addiction Treatments Remains Limited in Pharmacies
Despite policy efforts to improve access, many U.S. pharmacies still do not carry buprenorphine, highlighting ongoing disparities, especially in minority and rural communities.
Increasing Dizziness Cases in Minnesota Clinics Reflect Growing Awareness and Treatment Options
Minnesota clinics are seeing a rise in patients seeking care for dizziness and balance issues, driven by an aging population and improved treatment options. Advances in diagnosis and therapy are helping patients manage vertigo and prevent falls. Read more about the growing focus on vestibular health in Minnesota.